Deciphera Pharmaceuticals (DCPH) SEC Filings & 10K Form

$14.67
+0.09 (+0.62%)
(As of 04/23/2024 ET)

Recent Deciphera Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/22/2024
6:10 AM
Deciphera Pharmaceuticals (Filer)
Form PRER14A
04/11/2024
6:10 AM
Deciphera Pharmaceuticals (Filer)
Form PRE 14A
02/14/2024
1:26 PM
ARMISTICE CAPITAL, LLC (Filed by)
Deciphera Pharmaceuticals (Subject)
Form SC 13G/A
02/12/2024
4:32 PM
Deciphera Pharmaceuticals (Subject)
Flynn James E (Filed by)
Form SC 13G/A
02/09/2024
3:30 PM
Brightstar Associates LLC (Filed by)
Deciphera Pharmaceuticals (Subject)
Form SC 13G/A
02/09/2024
3:30 PM
Brightstar Associates LLC (Reporting)
Deciphera Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2024
6:52 AM
Deciphera Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/07/2024
6:11 AM
Deciphera Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/06/2024
3:52 PM
Deciphera Pharmaceuticals (Subject)
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Form SC 13G/A
02/06/2024
6:10 AM
Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2024
8:45 AM
Deciphera Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/18/2024
3:15 PM
Deciphera Pharmaceuticals (Issuer)
Squarer Ron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:15 PM
Deciphera Pharmaceuticals (Issuer)
Martin Daniel C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:15 PM
Allen Patricia L (Reporting)
Deciphera Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:15 PM
Deciphera Pharmaceuticals (Issuer)
Kelly Thomas Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:15 PM
Deciphera Pharmaceuticals (Issuer)
Friedman Franklin Stuart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:15 PM
Deciphera Pharmaceuticals (Issuer)
Pitman Jama (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:15 PM
Deciphera Pharmaceuticals (Issuer)
Walsh Dennis Leo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:15 PM
Deciphera Pharmaceuticals (Issuer)
Sherman Matthew L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
6:14 AM
Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2023
3:05 PM
Deciphera Pharmaceuticals (Issuer)
Martin Daniel C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2023
5:05 PM
Deciphera Pharmaceuticals (Subject)
Martin Daniel C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/30/2023
6:06 AM
Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2023
6:11 AM
Deciphera Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/05/2023
3:15 PM
Deciphera Pharmaceuticals (Issuer)
Dhanak Dashyant (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/09/2023
6:06 AM
Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2023
6:09 AM
Deciphera Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/23/2023
3:05 PM
Allen Patricia L (Reporting)
Deciphera Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:05 PM
Deciphera Pharmaceuticals (Issuer)
Squarer Ron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:05 PM
Deciphera Pharmaceuticals (Issuer)
Kelley Susan L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:05 PM
Deciphera Pharmaceuticals (Issuer)
Walsh Dennis Leo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:05 PM
Deciphera Pharmaceuticals (Issuer)
Friedman Franklin Stuart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:05 PM
Bristol James Arthur (Reporting)
Deciphera Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:05 PM
Benz Edward J. JR (Reporting)
Deciphera Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:05 PM
Deciphera Pharmaceuticals (Issuer)
Martin John Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
3:06 PM
Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2023
3:05 PM
Deciphera Pharmaceuticals (Issuer)
Flynn Daniel Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
3:05 PM
Deciphera Pharmaceuticals (Issuer)
Martin Daniel C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
3:05 PM
Deciphera Pharmaceuticals (Issuer)
Kelly Thomas Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
3:05 PM
Deciphera Pharmaceuticals (Issuer)
Sherman Matthew L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
3:05 PM
Deciphera Pharmaceuticals (Issuer)
Pitman Jama (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (Ad)

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

See how you can invest alongside him
05/03/2023
7:45 AM
Deciphera Pharmaceuticals (Filer)
Form S-3ASR
05/03/2023
6:07 AM
Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2023
6:10 AM
Deciphera Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2023
7:05 AM
Deciphera Pharmaceuticals (Filer)
Form DEF 14A
04/26/2023
7:06 AM
Deciphera Pharmaceuticals (Filer)
Form DEFA14A
04/26/2023
7:14 AM
Deciphera Pharmaceuticals (Filer)
Form ARS
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:DCPH) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners